OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
New Therapeutic Targets and Drugs for Schizophrenia Beyond Dopamine D2 Receptor Antagonists
Aineng Peng, Chai Jian-bo, Haiyuan Wu, et al.
Neuropsychiatric Disease and Treatment (2024) Vol. Volume 20, pp. 607-620
Open Access | Times Cited: 8
Aineng Peng, Chai Jian-bo, Haiyuan Wu, et al.
Neuropsychiatric Disease and Treatment (2024) Vol. Volume 20, pp. 607-620
Open Access | Times Cited: 8
Showing 8 citing articles:
The New Horizon of Antipsychotics beyond the Classic Dopaminergic Hypothesis—The Case of the Xanomeline–Trospium Combination: A Systematic Review
Octavian Vasiliu, Beatrice Budeanu, Mihai-Ștefan Cătănescu
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 610-610
Open Access | Times Cited: 4
Octavian Vasiliu, Beatrice Budeanu, Mihai-Ștefan Cătănescu
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 610-610
Open Access | Times Cited: 4
Role of Glial Cells and Receptors in Schizophrenia Pathogenesis
Yousef Tizabi, Marta C. Antonelli, Daniela Tizabi, et al.
Neurochemical Research (2025) Vol. 50, Iss. 2
Closed Access
Yousef Tizabi, Marta C. Antonelli, Daniela Tizabi, et al.
Neurochemical Research (2025) Vol. 50, Iss. 2
Closed Access
Unraveling the potential of neuroinflammation and autophagy in schizophrenia
Hongxia Tao, Cheng‐Xiang Wang, Chuan Zou, et al.
European Journal of Pharmacology (2025) Vol. 997, pp. 177469-177469
Closed Access
Hongxia Tao, Cheng‐Xiang Wang, Chuan Zou, et al.
European Journal of Pharmacology (2025) Vol. 997, pp. 177469-177469
Closed Access
Xylazine as an emerging new psychoactive substance; focuses on both 5‐HT7 and κ‐opioid receptors' molecular interactions and isosteric replacement
Giuseppe Floresta, Alberto Granzotto, Vincenzo Patamia, et al.
Archiv der Pharmazie (2025) Vol. 358, Iss. 3
Open Access
Giuseppe Floresta, Alberto Granzotto, Vincenzo Patamia, et al.
Archiv der Pharmazie (2025) Vol. 358, Iss. 3
Open Access
Does KarXT (xanomeline-trospium) represent a novel approach to schizophrenia management? A GRADE-assessed systematic review and meta-analysis of randomized controlled clinical trials
Hazem Mohammed, M. Gomaa, Y. Khalifa, et al.
BMC Psychiatry (2025) Vol. 25, Iss. 1
Open Access
Hazem Mohammed, M. Gomaa, Y. Khalifa, et al.
BMC Psychiatry (2025) Vol. 25, Iss. 1
Open Access
Daidzin enhances memory and the antischizophrenia drug olanzapine's effects, possibly through the 5‐HT2A and D2 receptor interaction pathways
Muhammad Torequl Islam, Raihan Chowdhury, Md. Shimul Bhuia, et al.
Drug Development Research (2024) Vol. 85, Iss. 6
Closed Access | Times Cited: 2
Muhammad Torequl Islam, Raihan Chowdhury, Md. Shimul Bhuia, et al.
Drug Development Research (2024) Vol. 85, Iss. 6
Closed Access | Times Cited: 2
The New Horizon of Antipsychotics beyond the Classic Dopaminergic Hypothesis—The Case of the Xanomeline-Trospium Combination: A Systematic Review
Octavian Vasiliu, Beatrice Budeanu, Mihai Stefan Catanescu
(2024)
Open Access | Times Cited: 1
Octavian Vasiliu, Beatrice Budeanu, Mihai Stefan Catanescu
(2024)
Open Access | Times Cited: 1
Drug-induced parkinsonism: diagnosis and treatment
HO Conn, Joseph Jankovic
Expert Opinion on Drug Safety (2024), pp. 1-11
Closed Access | Times Cited: 1
HO Conn, Joseph Jankovic
Expert Opinion on Drug Safety (2024), pp. 1-11
Closed Access | Times Cited: 1
How antipsychotics work in schizophrenia: a primer on mechanisms
Jonathan M. Meyer
CNS Spectrums (2024) Vol. 30, Iss. 1
Open Access
Jonathan M. Meyer
CNS Spectrums (2024) Vol. 30, Iss. 1
Open Access
